Dr Keating brings a executive experience in the global healthcare industry, where he has combined technical expertise with a record in bringing innovative health solutions through to commercialisation. Prior to his appointment to the Board of TrivarX, Dr Keating was the co-founder and Chief Executive Officer of ResApp Health. Following the acquisition, he transitioned to the role of Vice President at Pfizer to manage the integration of ResApps business. Prior to co-founding ResApp, Dr Keating was the Director of Commercial Engagement at UniQuest, the commercialisation arm of The University of Queensland (UQ).
